Insider · CIK 0001865698
Jeff Teper
Files at AVPT (AvePoint, Inc.). First filing -, latest -.
Jeff Teper files SEC Form 4 as director at AVPT (AvePoint, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jeff Teper has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | AVPT AvePoint, Inc. | AGrant or award Common Stock | +16,493 | $11.52 | $190k | 335,798 | Jun 3, 2026 |
| Jun 20, 2025 | AVPT AvePoint, Inc. | AGrant or award Common Stock | +9,744 | $17.96 | $175k | 319,305 | Jun 24, 2025 |
| Dec 20, 2024 | AVPT AvePoint, Inc. | AGrant or award Common Stock | +3,001 | $17.76 | $53k | 309,561 | Dec 26, 2024 |
| Dec 10, 2024 | AVPT AvePoint, Inc. | AGrant or award Common Stock | +3,000 | $18.22 | $55k | 311,007 | Dec 12, 2024 |
| Dec 10, 2024 | AVPT AvePoint, Inc. | AGrant or award Common Stock | +3,000 | $18.53 | $56k | 314,007 | Dec 12, 2024 |
Questions about Jeff Teper
Answered from the filings on this page, as of the latest one.
Is Jeff Teper buying or selling?
Jeff Teper has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jeff Teper's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jeff Teper has 0.
Where does Jeff Teper file Form 4?
Jeff Teper has filed Form 4 at AVPT (AvePoint, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.